USAEUROPEViVE
ABOUTSPONSORSHIPFOUNDATION
Logo Hlth
Logo Hlth
19 Apr 2022 | 02:45 PM GMT

DTx in Neurology: How to increase the HCP and Patient Adoption rates?

Anchored by:

Richelle Flanagan
Co-Founder
MY MOVES MATTER
Richie Bavasso
President
PNEUMOWAVE

Participants:

Richelle Flanagan Co-FounderMy Moves Matter
Richelle Flanagan
Co-FounderMy Moves Matter
Richie Bavasso PresidentPneumoWave
Richie Bavasso
PresidentPneumoWave
Abhishek Shah Co-Founder & CEOWellthy Therapeutics Pvt. Ltd.
Abhishek Shah
Co-Founder & CEOWellthy Therapeutics Pvt. Ltd.
Ivan Jurisic Head of ProductPatients Influence
Ivan Jurisic
Head of ProductPatients Influence
Krys Zaluski Director, External GrowthBiogen
Krys Zaluski
Director, External GrowthBiogen
Shrawan Patel Co-Founder & General PartnerPharmStars
Shrawan Patel
Co-Founder & General PartnerPharmStars

About this Meeting

Are you working in the neurology DTx space? Keep reading! 

Digital health tools in neurology have many applications - from being used in pediatrics (ADHD) to geriatrics (Alzheimer's, dementia) and across use cases such as cognition, stroke rehabilitation, motor symptom and pain management, to list a few. However, HCP and patient adoption rates seem to be lower compared to other Therapeutic Areas (TAs). How can we increase these rates for DTx in Neurology? Join this meeting to learn from other members in the HealthXL Neurology Community. We will have an informal conversation about:  

  • Current levels of adoption - why are these lower compared to other TAs?
  • How to increase HCP and patient awareness, drive activation and ensure proper onboarding to digital products as well as long-term retention. What is the impact of initiatives with patient advocacy groups and KOLs?
  • The role of physicians, nurses, pharmacists and caregivers to keep patients engaged
  • Integration of DTx solutions into neurologists’ & care team tools and workflows